Project Grant R61DA061375
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,422,000.00 in funding to Kaiser Foundation Hospitals to develop and assess the feasibility and efficacy of a mobile health (mHealth) intervention for young adult women affected by sex trafficking. The project aims to address the significant health risks and lack of accessible services for this population, including increased rates of substance...
- The National Institute on Drug Abuse (NIDA) awarded a $2,729,018 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Rhode Island. The purpose of this 2-year award, with a start date of September 15, 2024, is to rigorously develop and evaluate a mobile health intervention for adults with co-occurring opioid use disorder (OUD) and post-traumatic stress disorder (PTSD) during community re-entry after residential OUD treatment. The proposed mobile app...
- This federal Project Grant award of $516,981 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to adapt and evaluate the feasibility, acceptability, and preliminary efficacy of the Safe and Health Experiences (SHE) program for use in opioid use disorder (OUD) care settings (SHE-OUD). The SHE-OUD program aims to screen women seeking OUD treatment for lifetime sexual victimization (SV) and co-occurring issues like...
- This $246,012 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will assess whether a digital, survivor-crowdsourced intervention can increase HIV/STI/HCV testing and overdose prevention kit utilization among survivors of sex trafficking living in New York City. The project aims to: 1) develop crowdsourced digital messages to promote HIV/STI/HCV testing and overdose prevention service utilization, 2) compare the...
- This federal Project Grant award of $182,249, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the implementation and evaluation of a digitally enhanced intervention called EMPWR (Empowering Pregnant Women Receiving Medications for Opioid Use Disorder). The primary objectives of this grant are to: (1) Evaluate the feasibility of implementing the EMPWR intervention, which is designed to improve retention of pregnant...
- This federal Project Grant award of $1,948,634.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to adapt and test a smartphone-based mobile health (mHealth) intervention to reduce overdose risk among people who engage in polysubstance use. The study will build on previous research findings on polysubstance use patterns to develop the "OD-CHESS" intervention by adapting an existing substance use disorder...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $348,756 to the University of Oklahoma Health Sciences Center to develop a mobile health (mHealth) intervention for postpartum individuals recovering from opioid use disorder (OUD). The goal of the proposed research is to create an mHealth intervention grounded in Acceptance and Commitment Therapy (ACT) principles that can provide...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $677,250 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Miami. The grant, awarded on June 15, 2025, supports the development and testing of the "Healthcare Empowerment and Advocacy for Recovery from Trafficking (HEART) Intervention" for implementation in syringe service programs. The project aims to engage women with experiences of...
- This Project Grant award of $1,573,958 from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), is focused on identifying individuals who are viremic and/or have substance use disorder (SUD) to engage them for early intervention. The project will implement routine SUD screening using the NIDA Quick Screen and a social network intervention to find individuals who are viremic, have SUD, or both, and link them to harm reduction and HIV...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to develop and evaluate an adaptive psychological intervention to improve pain management and reduce opioid use following an injury. The $264,995 grant, awarded on September 15, 2025, will fund the optimization and feasibility testing of a two-part intervention. The first part is a 15-minute computerized brief intervention focused on...
This $500,014 federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support the development and testing of a mobile health (mHealth) intervention called WINGS+++. The WINGS+++ intervention integrates screening, brief intervention, and referral tools to address intimate partner violence (IPV), post-traumatic stress disorder (PTSD), and opioid/substance use disorders (OUD/SUD) among women. This 6-year project, from September 1, 2025 to August 31, 2027, will first pilot-test the feasibility, acceptability, and safety of WINGS+++ with 30 women in Orange County, New York, and then conduct a larger effectiveness-implementation trial to evaluate the intervention's impact. The project aims to improve identification of IPV and PTSD and enhance linkages to appropriate services for women with OUD/SUD, in order to address these critical co-occurring issues and improve treatment outcomes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $500.0k | 8/29/25 |